Related Experiment Video
Updated: Aug 9, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
SELENOF functions as a tumor suppressor in skin cancer
Brenna Flowers1, An Zhang1, Weiwei Ma2
1Department of Cancer Biology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, 60153, USA.
Abstract:
Selenoprotein F (SELENOF) is one of the 25 human selenoproteins that is highly sensitive to fluctuations in bioavailable selenium, an essential micronutrient. Although SELENOF has been implicated in cancer etiology, its precise role remains unclear. To define its contribution to carcinogenesis, Selenof knockout (KO) mice were exposed to the potent carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) and fed a high-fat, high-calorie Western diet. All Selenof KO mice developed tumors and did so more rapidly, whereas only 30% of wild-type mice developed tumors. This effect was further exacerbated by the Western diet regardless of Selenof status. Notably, the majority of DMBA-induced tumors in KO mice were skin lesions, predominantly cutaneous squamous cell carcinomas (SCCs) and benign papillomas. These tumors occurred at a four-fold higher frequency in KO mice than in wild-type controls, establishing SELENOF as a key tumor suppressor in the skin. To assess the relevance of these findings to human disease, we analyzed a skin cancer microarray containing patient samples of SCC, basal cell carcinoma, melanomas, and matched adjacent normal tissue. SELENOF expression was dramatically reduced across all tumor types relative to normal skin. Although the skin of Selenof KO mice appears histologically normal, transcriptomic profiling followed by enrichment analysis revealed significant downregulation of pathways related to epidermal development and keratinocyte differentiation as well as the upregulation of oxidative phosphorylation and mitochondrial metabolic pathways. Collectively, these findings support a causal link between SELENOF loss and skin cancer development and highlight a previously unrecognized role for SELENOF in safeguarding against skin carcinogenesis. Significance: Skin cancers are the most common human malignancies. SELENOF levels are significantly reduced in skin cancers, and experimental evidence establishes a critical tumor-suppressive role for SELENOF in the skin.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
